Healthtech Startups

Oska Health provides continuous care management for people with chronic kidney disease, aiming to reduce complications, hospitalizations, and healthcare costs through integrated digital and clinical support.

2 investors

Otos is a platform that combines hearing and cognitive health assessment into a single system, with automated testing, triage, and continuous patient monitoring for integration into clinical workflows. It serves health systems, ENT and audiology practices, primary care, neurology, and longevity clinics, and is running clinical validation and pilot programs in Europe and the U.S.

2 investors

OTTAA Project is a mobile augmentative and alternative communication (AAC) system for people with speech disabilities, letting users build phrases from internationally recognized pictograms. The tool is customizable, supports multiple languages, and includes accessibility features for users with motor impairments such as hemiplegia, spasticity, cerebral palsy, or stroke.

2 investors

Ottimo is a biotech company developing oncology and immuno-oncology therapeutics, including antibody-based cancer treatments. Its leadership and preclinical work focus on discovery through clinical development of cancer therapies.

2 investors

Ourry Medical is a healthcare company focused on integrating and improving expertise centered on patient outcomes, combining technology and human expertise to deliver comprehensive solutions for healthcare needs.

2 investors

OutcomeMD operates a data network that collects patient-reported outcome measures (PROMs) from clinicians and transforms them into insights for providers, health systems, and researchers. The platform serves healthcare providers, practice groups, biopharma companies, and researchers seeking to improve patient outcomes and access real-world clinical data.

2 investors

Outfox Health uses AI tools to help American workers and employers reduce healthcare costs by providing transparency and information about healthcare pricing, delivery, and outcomes. The company addresses the information asymmetry in the U.S. healthcare system that has driven costs to over 10% of household income.

2 investors

Complement sells nutritional supplements directly to consumers, offering a 100-day money-back guarantee on all orders. The brand markets to a broad range of health-focused customers, from athletes to newcomers, with an emphasis on product transparency.

2 investors

Overdrive Defense makes consumer drug testing kits, including fentanyl test kits and drink spike test kits, for personal safety in high-risk settings such as nightlife and street environments. The company markets its products directly to civilians and partners with nonprofits to distribute them.

2 investors

Overfit combines human coaching for accountability with AI-generated personalized workout plans for fitness users seeking guidance and customized exercise routines.

2 investors

Ovid Therapeutics develops medicines for children and adults with epilepsies and brain conditions, focusing on anti-seizure and neurological treatments. The company is led by a team with decades of combined experience in biotech and pharmaceutical development, having supported the launch of more than 25 new medicines.

2 investors

Owlo develops patented optical imaging technology that enables non-invasive, real-time 3D imaging deep within biological tissue. The company targets applications in IVF, drug discovery, and ophthalmology.

2 investors

Owlstone Medical develops a breath-based diagnostic platform for non-invasive disease detection across respiratory conditions, cancers, and digestive health. The company serves academic, clinical, and pharmaceutical research partners seeking to develop breath biomarker applications for precision medicine and early diagnosis.

2 investors

Oxford Biomedica is a biopharmaceutical contract development and manufacturing organization (CDMO) specializing in cell and gene therapies, lentiviral vector technologies, and bioprocessing solutions. The company provides manufacturing, development, and technical services to clients developing advanced therapies.

2 investors

Oxford Brain Diagnostics provides CDM Insights, a clinical software platform that analyzes MRI scans to detect and monitor microstructural changes in the brain for early diagnosis of neurodegenerative conditions. The platform integrates with standard hospital MRI systems and delivers quantitative brain assessment reports to clinicians within 12 hours.

2 investors

Oxford Medical Simulation (OMS) provides immersive VR and AI-based clinical training scenarios for healthcare professionals and learners. Founded by clinicians, the platform aims to make clinical readiness measurable and repeatable for healthcare education organizations.

2 investors

A healthcare company that develops and supplies medicines, including new and more affordable therapies, aiming for reliable supply of needed treatments. Its offerings reference products such as a once-weekly combined hormonal contraceptive patch.

2 investors

Play Health builds a clinical decision-support platform for healthcare providers to deliver personalized menopause and women's health care. The platform serves primary care physicians and other providers treating women navigating perimenopause and menopause.

2 investors

Pacific Channel is a venture capital and investment firm focused on identifying, advancing, and investing in deep-tech startups in the sectors of food, health, and the environment. The firm partners with founders and portfolio companies to support commercialization and growth across multiple geographic markets.

2 investors

A U.S. developer of a mobile mental health application grounded in cognitive behavioral therapy. The app breaks CBT and relaxation techniques into short daily exercises and lets users track progress as they work on stress, anxiety, and depression.

2 investors

PAGE Therapeutics is an oncology drug development company developing compounds that disrupt cell-cell adhesion to dissolve circulating tumor cell (CTC) clusters and block cancer metastasis. Its lead work includes preclinical models and a proof-of-concept clinical trial in breast cancer patients.

2 investors

Paige Frame makes a digital photo frame designed for staying connected with family without passwords, logins, or complicated setup. The product targets consumers who want a simple way to share and view photos with loved ones.

2 investors

PainTEQ develops medical devices and implants for sacroiliac joint dysfunction, offering solutions ranging from biologicalbone allografts to titanium implants as alternatives to injections or fusion surgery. The company focuses exclusively on sacroiliac joint treatment for patients and physicians.

2 investors

Pairidex offers FusionMRD, a personalized digital droplet PCR (ddPCR) assay that detects and quantifies oncogenic gene fusions from a standard peripheral blood sample to monitor treatment response and minimal residual disease in gene fusion-driven blood cancers such as leukemia. It is sold as a commercial service for oncologists and clinical researchers to support treatment decisions and shorten clinical trial timelines.

2 investors